Relaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study
- PMID: 26970832
- PMCID: PMC4851559
- DOI: 10.1016/j.jchf.2016.01.004
Relaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study
Abstract
Objectives: This study explored the association of vascular hormones with myocardial recovery and clinical outcomes in peripartum cardiomyopathy (PPCM).
Background: PPCM is an uncommon disorder with unknown etiology. Angiogenic imbalance may contribute to its pathophysiology.
Methods: In 98 women with newly diagnosed PPCM enrolled in the Investigation in Pregnancy Associated Cardiomyopathy study, serum was obtained at baseline for analysis of relaxin-2, prolactin, soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF). Left ventricular ejection fraction (LVEF) was assessed by echocardiography at baseline and 2, 6, and 12 months.
Results: Mean age was 30 ± 6 years, with a baseline of LVEF 0.35 ± 0.09. Relaxin-2, prolactin, and sFlt1 were elevated in women presenting early post-partum, but decreased rapidly and were correlated inversely with time from delivery to presentation. In tertile analysis, higher relaxin-2 was associated with smaller left ventricular systolic diameter (p = 0.006) and higher LVEF at 2 months (p = 0.01). This was particularly evident in women presenting soon after delivery (p = 0.02). No relationship was evident for myocardial recovery and prolactin, sFlt1 or VEGF levels. sFlt1 levels were higher in women with higher New York Heart Association functional class (p = 0.01) and adverse clinical events (p = 0.004).
Conclusions: In women with newly diagnosed PPCM, higher relaxin-2 levels soon after delivery were associated with myocardial recovery at 2 months. In contrast, higher sFlt1 levels correlated with more severe symptoms and major adverse clinical events. Vascular mediators may contribute to the development of PPCM and influence subsequent myocardial recovery. (Investigation in Pregnancy Associate Cardiomyopathy [IPAC]; NCT01085955).
Keywords: cardiomyopathy; heart failure; hormones; pregnancy and post-partum.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Figures




Comment in
-
The Search for a Crystal Ball to Predict Early Recovery From Peripartum Cardiomyopathy?JACC Heart Fail. 2016 May;4(5):389-91. doi: 10.1016/j.jchf.2016.03.017. JACC Heart Fail. 2016. PMID: 27126284 No abstract available.
-
BMI Is a Potential Confounder of Postpartum Relaxin-2 and Short-Term Left Ventricular Function Following Peripartum Cardiomyopathy.JACC Heart Fail. 2016 Jul;4(7):605. doi: 10.1016/j.jchf.2016.03.015. JACC Heart Fail. 2016. PMID: 27364970 No abstract available.
-
Reply: BMI Is a Potential Confounder of Post-Partum Relaxin-2 and Short-Term Left Ventricular Function Following Peripartum Cardiomyopathy.JACC Heart Fail. 2016 Jul;4(7):605-606. doi: 10.1016/j.jchf.2016.04.002. JACC Heart Fail. 2016. PMID: 27364971 No abstract available.
-
Reducing the risks for relapse of heart failure in a subsequent pregnancy after peripartum cardiomyopathy?Future Cardiol. 2017 Jul;13(4):305-310. doi: 10.2217/fca-2017-0029. Epub 2017 Jun 16. Future Cardiol. 2017. PMID: 28621169 No abstract available.
References
-
- Elkayam U. Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. Journal of the American College of Cardiology. 2011;58(7):659–70. - PubMed
-
- Chapa JB, Heiberger HB, Weiner L, Decara J, Lang RM, Hibbard JU. Prognostic value of echocardiography in peripartum cardiomyopathy. Obstetrics and Gynecology. 2005;105(6):1303–8. - PubMed
-
- Mielniczuk LM, Williams K, Davis DR, Tang AS, Lemery R, Green MS, Gollob MH, Haddad H, Birnie DH. Frequency of peripartum cardiomyopathy. American Journal of Cardiology. 2006;97(12):1765–8. - PubMed
-
- Brar SS, Khan SS, Sandhu GK, Jorgensen MB, Parikh N, Hsu JW, Shen AY. Incidence, mortality, and racial differences in peripartum cardiomyopathy. American Journal of Cardiology. 2007;100(2):302–4. - PubMed
-
- Gunderson EP, Croen LA, Chiang V, Yoshida CK, Walton D, Go AS. Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomes. Obstetrics and Gynecology. 2001;118(3):583–91. - PubMed